Description

Carbamic Acid, [3-Fluoro-4-(4-Morpholinyl)Phenyl]-, Ethyl Ester is a high-purity, advanced pharmaceutical intermediate featuring a unique molecular scaffold combining a fluorinated aromatic ring with a morpholine moiety. This compound is of significant commercial interest for its role in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular interactions. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities for oncology, central nervous system (CNS) disorders, and other specialized treatments.

Application

• Pharmaceutical Intermediate: A key building block in the research and synthesis of novel drug candidates, especially kinase inhibitors and receptor modulators.
• Organic Synthesis Research: Used in academic and industrial R&D for constructing complex heterocyclic compounds and exploring structure-activity relationships (SAR).
• Preclinical Drug Development: Serves as a critical precursor in the scale-up and process optimization stages for new therapeutic agents.
• Chemical Reference Standard: Employed as an analytical standard for quality control and method validation in API manufacturing.
• Agrochemical Research: Potential intermediate in the development of new generation crop protection agents with enhanced efficacy.
• Material Science: Exploration of its use in the synthesis of specialty polymers or organic electronic materials due to its specific aromatic and heterocyclic structure.

Basic Information

Product Name	Carbamic Acid, [3-Fluoro-4-(4-Morpholinyl)Phenyl]-, Ethyl Ester
CAS No.	565176-83-2
Molecular Formula	C13H17FN2O3
Molecular Weight	268.29 g/mol
Synonyms	Ethyl N-[3-Fluoro-4-(4-morpholinyl)phenyl]carbamate; 3-Fluoro-4-morpholinophenyl ethylcarbamate; Ethyl (3-Fluoro-4-morpholinophenyl)carbamate; Carbamic acid, N-[3-fluoro-4-(4-morpholinyl)phenyl]-, ethyl ester; UNII-9J3B8S5I2F; 9J3B8S5I2F; Ethyl 3-fluoro-4-morpholinophenylcarbamate; BDBM50111657
EINECS	Contact for details

Quality Control

Our Carbamic Acid, [3-Fluoro-4-(4-Morpholinyl)Phenyl]-, Ethyl Ester is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and stringent control of residual solvents and impurities to meet the exacting standards of pharmaceutical R&D. Certificates of Analysis (COA) with full traceability are provided for every shipment, ensuring reliable and consistent performance in your critical synthesis workflows.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.